In vitro erythropoiesis of cord blood haematopoietic stem cells (HSCs) to produce fully enucleated red blood cells could provide an alternate resource for the erythrocyte. However, haematopoietic processes are highly complex and dynamic; defining process requirements to produce reproducible cells of high purity and yield is not an easy task. One major obstacle is the lack of knowledge in process characteristics. Design of experiments (DOE) is proposed as a tool to unveil process complexities that exists in HSC cultures. Characterisation and optimisation of in vitro erythropoiesis as a single-step culture is first performed via a simple DOE experimental strategy. The optimised DOE culture produced significantly better results (higher...
AbstractBackground aimsEconomic ex vivo manufacture of erythrocytes at 1012 cell doses requires an e...
Stem cell-based therapies have been proposed as promising for the maintenance, regeneration, or repl...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...
In vitro erythropoiesis of cord blood haematopoietic stem cells (HSCs) to produce fully enucleated r...
The need for successful ex-vivo expansion and directed differentiation of haematopoietic stem cells ...
Proliferation and differentiation of haematopoietic stem cells (HSCs) from umbilical cord blood at l...
For decades, research has been focussed on finding a way to produce artificial blood as a resolution...
Cell culture is a complex and dynamic process. Efficient optimisation of economic production, proces...
Erythropoiesis studies have been hampered by the lack of culture systems that accurately reproduce t...
Human red blood cell production, or erythropoiesis, occurs within bone marrow. Living animal and hum...
In vitro culture studies of hematopoietic cells (HCs) have traditionally been limited to dose-respon...
Background aims: Economic ex vivo manufacture of erythrocytes at 10 cell doses requires an efficient...
This article describes a good manufacturing practice (GMP)-compatible, feeder-free and serum-free me...
Although the current system of blood transfusion is relatively safe and established within the UK, p...
In vitro production of erythrocytes in physiologic numbers from human induced pluripotent stem cells...
AbstractBackground aimsEconomic ex vivo manufacture of erythrocytes at 1012 cell doses requires an e...
Stem cell-based therapies have been proposed as promising for the maintenance, regeneration, or repl...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...
In vitro erythropoiesis of cord blood haematopoietic stem cells (HSCs) to produce fully enucleated r...
The need for successful ex-vivo expansion and directed differentiation of haematopoietic stem cells ...
Proliferation and differentiation of haematopoietic stem cells (HSCs) from umbilical cord blood at l...
For decades, research has been focussed on finding a way to produce artificial blood as a resolution...
Cell culture is a complex and dynamic process. Efficient optimisation of economic production, proces...
Erythropoiesis studies have been hampered by the lack of culture systems that accurately reproduce t...
Human red blood cell production, or erythropoiesis, occurs within bone marrow. Living animal and hum...
In vitro culture studies of hematopoietic cells (HCs) have traditionally been limited to dose-respon...
Background aims: Economic ex vivo manufacture of erythrocytes at 10 cell doses requires an efficient...
This article describes a good manufacturing practice (GMP)-compatible, feeder-free and serum-free me...
Although the current system of blood transfusion is relatively safe and established within the UK, p...
In vitro production of erythrocytes in physiologic numbers from human induced pluripotent stem cells...
AbstractBackground aimsEconomic ex vivo manufacture of erythrocytes at 1012 cell doses requires an e...
Stem cell-based therapies have been proposed as promising for the maintenance, regeneration, or repl...
For almost two decades it is claimed that cell-based therapies will revolutionize the field of medic...